Hedgehog pathway inhibition has been proven to be an effective anti-cancer therapeutic strategy and the inhibitors or small molecular modulators for Hh/Gli signaling target on SMO and Gli1 (Rimkus et al., 2016). The gene discussed is SMO; the disease is cancer.